NI201700057A - Método para tratar, prevenir o reducir el riesgo de infección cutánea - Google Patents

Método para tratar, prevenir o reducir el riesgo de infección cutánea

Info

Publication number
NI201700057A
NI201700057A NI201700057A NI201700057A NI201700057A NI 201700057 A NI201700057 A NI 201700057A NI 201700057 A NI201700057 A NI 201700057A NI 201700057 A NI201700057 A NI 201700057A NI 201700057 A NI201700057 A NI 201700057A
Authority
NI
Nicaragua
Prior art keywords
treat
risk
prevent
reduce
skin infection
Prior art date
Application number
NI201700057A
Other languages
English (en)
Inventor
M Duffy Erin
Original Assignee
Melinta Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Therapeutics Inc filed Critical Melinta Therapeutics Inc
Publication of NI201700057A publication Critical patent/NI201700057A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a métodos para tratar acné y otras infecciones cutáneas causadas o mediadas por Propionibacterium acnes, Gardnerella vaginalis o Staphylococcus aureus en un paciente con una cantidad segura y efectiva de un compuesto antibiótico de oxazolidinona aplicado tópicamente.
NI201700057A 2014-11-14 2017-05-12 Método para tratar, prevenir o reducir el riesgo de infección cutánea NI201700057A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462080212P 2014-11-14 2014-11-14

Publications (1)

Publication Number Publication Date
NI201700057A true NI201700057A (es) 2017-09-04

Family

ID=55955188

Family Applications (1)

Application Number Title Priority Date Filing Date
NI201700057A NI201700057A (es) 2014-11-14 2017-05-12 Método para tratar, prevenir o reducir el riesgo de infección cutánea

Country Status (21)

Country Link
US (1) US10471046B2 (es)
EP (1) EP3217974A4 (es)
JP (1) JP2017534654A (es)
KR (1) KR20170084200A (es)
CN (1) CN107205989A (es)
AR (1) AR102666A1 (es)
AU (1) AU2015346023A1 (es)
BR (1) BR112017009989A2 (es)
CA (1) CA2967825A1 (es)
CL (1) CL2017001245A1 (es)
CR (1) CR20170196A (es)
EA (1) EA201791051A1 (es)
HK (1) HK1244211A1 (es)
IL (1) IL252197A0 (es)
MX (1) MX2017006319A (es)
NI (1) NI201700057A (es)
PH (1) PH12017500887A1 (es)
SG (1) SG11201703856VA (es)
SV (1) SV2017005444A (es)
UY (1) UY36402A (es)
WO (1) WO2016077818A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10464896B2 (en) 2015-06-11 2019-11-05 Basilea Pharmaceutica International AG Efflux-pump inhibitors and therapeutic uses thereof
JP7174700B2 (ja) * 2016-12-09 2022-11-17 セルタクシー、エルエルシー ロイコトリエンａ４ヒドロラーゼの阻害剤としてのモノアミン及びモノアミン誘導体
CN107721943A (zh) * 2017-10-26 2018-02-23 沈阳药科大学 含联芳基腙结构的噁唑烷酮类化合物及其制备方法
KR20190130243A (ko) 2018-05-14 2019-11-22 (주)텔리언 트러스트 인덱스를 이용한 공유경제 시스템 및 방법
CN115677679A (zh) * 2021-07-26 2023-02-03 沈阳药科大学 含联芳基腙结构的噁唑烷酮化合物及其制备方法和应用

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES332272A1 (es) 1965-10-20 1967-11-16 Milwaukee Chaplet & Mfg Company Inc Un dispositivo regulador de programa.
GB1185685A (en) 1966-01-11 1970-03-25 Quinoderm Ltd Method of Making Pharmaceutical Compositions
US3418055A (en) 1967-04-03 1968-12-24 Schwartzman Gilbert Pressure operated applicator and cap construction
US3410645A (en) 1967-05-08 1968-11-12 Schwartzman Gilbert Concave diaphragm applicator
US3535422A (en) 1968-03-11 1970-10-20 Stiefel Laboratories Stable benzoyl peroxide composition
US3669323A (en) 1969-12-12 1972-06-13 American Can Co One-way valve insert for collapsible dispensing containers
US4056611A (en) 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
GB1541463A (en) 1975-10-11 1979-02-28 Lion Dentifrice Co Ltd Process for prparing a multiple emulsion having a dispersing form of water-phase/oil-phase/water-phase
US4620648A (en) 1982-07-06 1986-11-04 Dab-O-Matic Corp. Pressure-responsive valve
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
US4693623A (en) 1984-03-02 1987-09-15 Dab-O-Matic Corp. Pressure-responsive valve for an applicator
US4999186A (en) 1986-06-27 1991-03-12 The Procter & Gamble Company Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn
US4937370A (en) 1987-06-02 1990-06-26 The Procter & Gamble Company Novel chromophores, sunscreen compositions and methods for preventing sunburn
US4960764A (en) 1987-03-06 1990-10-02 Richardson-Vicks Inc. Oil-in-water-in-silicone emulsion compositions
US4800197A (en) 1987-07-17 1989-01-24 Richardson-Vicks Inc. Anti-acne composition
US4891227A (en) 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4891228A (en) 1988-02-02 1990-01-02 Richardson-Vicks Inc. Medicated cleansing pads
US4919934A (en) 1989-03-02 1990-04-24 Richardson-Vicks Inc. Cosmetic sticks
US5087445A (en) 1989-09-08 1992-02-11 Richardson-Vicks, Inc. Photoprotection compositions having reduced dermal irritation
US5073371A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
US5073372A (en) 1990-11-30 1991-12-17 Richardson-Vicks, Inc. Leave-on facial emulsion compositions
AU667198B2 (en) 1991-11-01 1996-03-14 Pharmacia & Upjohn Company Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
US6107482A (en) 1995-03-27 2000-08-22 Isis Pharmaceuticals, Inc. Nitrogenous macrocyclic compounds
CA2290712C (en) 1995-09-22 2003-09-09 Wakunaga Pharmaceutical Co., Ltd. Novel pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective components
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
US6413981B1 (en) * 1999-08-12 2002-07-02 Ortho-Mcneil Pharamceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
EP1289984A4 (en) 2000-06-05 2004-11-24 Dong A Pharm Co Ltd NEW OXAZOLIDE DERIVATIVES AND A METHOD FOR THEIR PRODUCTION
US20130059774A1 (en) * 2000-08-01 2013-03-07 Mahesh Vithalbhai Patel Efflux pump inhibitors
US20030096850A1 (en) 2001-10-11 2003-05-22 Ford Charles W. Treating infections by administration of oxazolidinones
AR043050A1 (es) 2002-09-26 2005-07-13 Rib X Pharmaceuticals Inc Compuestos heterociclicos bifuncionales y metodos para preparar y usar los mismos
CN1780846A (zh) 2003-03-05 2006-05-31 Rib－X医药品有限公司 双官能杂环化合物及其制备和使用方法
AU2004267007C1 (en) 2003-06-03 2010-04-29 Melinta Subsidiary Corp. Biaryl heterocyclic compounds and methods of making and using the same
WO2005012271A2 (en) 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
US20060270680A1 (en) 2003-06-03 2006-11-30 Goldberg Joel A Sulfonamide compounds and methods of making and using the same
WO2005012270A2 (en) 2003-07-29 2005-02-10 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same
EP1713785A1 (en) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
JP2008508271A (ja) 2004-07-28 2008-03-21 リブ−エックス ファーマシューティカルズ，インコーポレイテッド ビアリール複素環式化合物ならびにその化合物を製造および使用する方法
EP2305666B1 (en) 2004-07-30 2014-06-25 AbbVie Inc. Preparation of pyridonecarboxylic acid antibacterials
LT3056492T (lt) 2004-10-08 2022-01-25 Abbvie Inc. Meglumino druska ir atitinkamos vaisto (delafloksacino) kristalinės formos
DK1868581T3 (da) 2005-04-11 2012-07-09 Abbott Lab Farmaceutiske sammensætninger med forbedrede opløsningsprofiler til dårligt opløselige lægemidler
KR101394307B1 (ko) 2005-06-08 2014-05-13 멜린타 테라퓨틱스, 인크. 트리아졸의 합성 방법
WO2007025089A2 (en) 2005-08-24 2007-03-01 Rib-X Pharmaceutical, Inc. Triazole compounds and methods of making and using the same
ES2638427T3 (es) 2005-08-24 2017-10-20 Melinta Therapeutics, Inc. Compuestos de triazol y procedimientos de preparación y uso del mismo
WO2011139832A2 (en) 2010-04-28 2011-11-10 Rib-X Pharmaceuticals, Inc. Method for treating mycobacterial infections

Also Published As

Publication number Publication date
US10471046B2 (en) 2019-11-12
SV2017005444A (es) 2017-08-31
EA201791051A1 (ru) 2018-01-31
CA2967825A1 (en) 2016-05-19
AR102666A1 (es) 2017-03-15
BR112017009989A2 (pt) 2018-01-02
US20160136137A1 (en) 2016-05-19
IL252197A0 (en) 2017-07-31
PH12017500887A1 (en) 2017-11-06
CR20170196A (es) 2017-07-10
EP3217974A1 (en) 2017-09-20
KR20170084200A (ko) 2017-07-19
WO2016077818A1 (en) 2016-05-19
CN107205989A (zh) 2017-09-26
EP3217974A4 (en) 2018-07-25
UY36402A (es) 2016-06-30
SG11201703856VA (en) 2017-06-29
JP2017534654A (ja) 2017-11-24
AU2015346023A1 (en) 2017-06-01
HK1244211A1 (zh) 2018-08-03
MX2017006319A (es) 2017-08-10
CL2017001245A1 (es) 2018-02-09

Similar Documents

Publication Publication Date Title
NI201700057A (es) Método para tratar, prevenir o reducir el riesgo de infección cutánea
CL2016002285A1 (es) Compuestos orgánicos de monobactam para el tratamiento de infecciones bacterianas
NI201600051A (es) Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores
CL2016003071A1 (es) Composiciones y métodos para tratar y prevenir infecciones por staphylococcus aureus
PH12017501646A1 (en) Antimicrobial compounds and methods of making and using the same
HK1220624A1 (zh) 抗微生物劑的組合物和製劑、它們的方法以及用於治療微生物感染的方法
CR20160308A (es) Combinaciones de inhibidores de histona deacetilasa y farmacos inmunomoduladores
TW201613575A (en) Treatment of polybacterial infections
PH12016500453A1 (en) Antimicrobial compounds and methods of making and using the same
CL2015002744A1 (es) Alimento para peces que comprende azadiractina, útil para el tratamiento y/o prevención de infecciones y/o infestaciones parasitarias, particularmente contra el piojo de mar lepeophtherius salmonis.
MX2015016319A (es) Terapia de combinacion que comprende oxazolidinona-quinolonas para uso en el tratamiento de infecciones bacterianas.
BR112017000520A2 (pt) composto ou sal do mesmo, uso um composto ou de um sal, e, kit.
BR112017000398A2 (pt) composto ou sal do mesmo, método de tratamento de uma infecção causada por dirofilaria immitis, e, kit.
NZ764310A (en) Antibacterial compounds
UY37245A (es) Formulaciones tópicas de compuestos heterocíclicos de biarilo y métodos de uso de estas
UY36196A (es) Compuestos para usar en el tratamiento antihelmíntico
DK3432900T3 (da) Mælkesyrebakteriesammensæting til behandling af bakterielle vaginale infektioner forårsaget af gardnerella vaginalis og, hvis de forefindes, samtidige svampeinfektioner
BR112016014099A2 (pt) método de tratamento de feridas
AR103636A1 (es) Métodos de tratamiento de neuralgia postherpética con una formulación tópica de un compuesto de espiro-oxindol
ECSP16095557A (es) Métodos para tratar infecciones
AR095401A1 (es) Método y composición del tratamiento de las semillas de canola
AR095402A1 (es) Método y composición del tratamiento de las semillas de canola
RU2014125665A (ru) Способ наружного лечения микозов кожи
AR114152A1 (es) Tratamiento antibacterial con cannabinoides
CR20160591A (es) Metodos para tratar infecciones